Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bellerophon Therapeutics Inc
BLPH
Healthcare
Biotechnology
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company’s focus is to develop its nitric oxide therapy for patients with pulmonary hypertension (PH) using its delivery system, INOpulse. The Company’s INOpulse program is an...
extension of the technology used in hospitals to deliver continuous flow inhaled nitric oxide. INOpulse program is built on scientific and technical development for the therapeutic delivery of inhaled nitric oxide. It is also developing INOpulse for the treatment of patients with fibrotic interstitial lung disease (fILD), PH-Sarcoidosis, PH-chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other pulmonary hypertension conditions. The Company’s subsidiaries include Bellerophon BCM LLC, Bellerophon Pulse Technologies LLC and Bellerophon Services, Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (PINL:BLPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 27, 2022 8:52am
BLPH ...NR this a.m....However !!!!
Nothing but a NR that they are reducing the study size.....Go back to bed ! Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 06, 2022 1:55pm
BLPH ....Take a look at the trades this a.m
This is a perfect example "Smoke & Mirrors" Mr. Maggot at his finest...... THis could be $5 in a blink of an eye. Tic F'ing Toc !!!!!!!!!!!!!!!!!!!!!
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 23, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 01, 2022 12:10pm
BLPH......Cheaper than a Large Slurpee ; )
Reversed Split 02/10/2022 ....15 : 1 I'd say they will be a share price increase to raise $'s Time will tell....JMHO Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jul 19, 2022 2:21pm
BLPH .... I like this here at ~ $1.30
Cheers !
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Feb 11, 2022 4:24pm
Nitric Oxide Company passes Phase 3
Canadian company SaNOtize’s COVID-19 treatment wins approval in India A treatment for COVID-19 that was developed in British Columbia has been approved for sale in India, where it could be shipped to
...more
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Dec 24, 2021 6:19pm
RE:RE:Volume is up
Yes keep your eye on this one, they're using Nitric Oxide in their process. N.O. is going to be Hot one of these days, front page news IMO
(30)
•••
MushLove
X
View Profile
View Bullboard History
Comment by
MushLove
on Dec 17, 2021 8:01pm
RE:Volume is up
A lot of Bio stocks are seeing increased volatility. New viruses every month and cannabis legalization in the US starting with safe banking is possibly why. That's a very generalized perspective,
...more
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Dec 17, 2021 11:16am
Volume is up
34 million traded so far today, that's 1000 times normal for this stock and today's not even half over
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Dec 17, 2021 9:40am
News
Bellerophon Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Dec 15, 2021 11:01am
Interesting
Interesting product
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 26, 2020 2:26pm
doing well
with this stock,so glta shareholders.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 25, 2020 8:48pm
steady hold for me
the markets are bad,so glta shareholders.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 19, 2020 8:52pm
profit taking along the way
that's o.k. by me,this one is only starting to go up with FDA trials coming up,so glta.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 18, 2020 1:53pm
still holding this stock
my target price is over twenty bucks per share,so glta shareholders.
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 18, 2020 11:49am
it's a buy today for me
at $5.65 per share this morning,it's off of my watchlist,so glta.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study